Evidence map›Paper›PMID 31027375›Full record

ArticleViruses2019

Targeted Editing of the

Yaoyao Zhang, Jun Luo, Na Tang, Man Teng, Vishwanatha R A P Reddy, Katy Moffat, Zhiqiang Shen, Venugopal Nair, Yongxiu Yao

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Yaoyao ZhangThe Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Surrey GU24 0NF, UK. zhangyaoyao3848@126.com.
Jun LuoKey Laboratory of Animal Immunology of the Ministry of Agriculture, Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China. luojun593@aliyun.com.
Na TangThe Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Surrey GU24 0NF, UK. tangna0543@163.com.
Man TengKey Laboratory of Animal Immunology of the Ministry of Agriculture, Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China. tm135@aliyun.com.
Vishwanatha R A P ReddyThe Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Surrey GU24 0NF, UK. Vishi.AvalakuppaPapiReddy@pirbright.ac.uk.
Katy MoffatThe Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Surrey GU24 0NF, UK. Kathryn.Moffat@pirbright.ac.uk.
Zhiqiang ShenBinzhou Animal Science and Veterinary Medicine Academy & UK-China Centre of Excellence for Research on Avian Diseases, Binzhou 256600, China. bzshenzq@163.com.
Venugopal NairThe Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Surrey GU24 0NF, UK. venugopal.nair@pirbright.ac.uk.
Yongxiu YaoThe Pirbright Institute & UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Surrey GU24 0NF, UK. yongxiu.yao@pirbright.ac.uk.
The Pirbright Institute · GBBinzhou Medical University · CNHenan Academy of Agricultural Sciences · CNHenan University of Science and Technology · CN

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007032 and BB/R007896/1
6 · The paper itself

Abstract

Marek's disease virus (MDV), a lymphotropic α-herpesvirus associated with T-cell lymphomas in chickens, is an excellent model for herpesvirus biology and virus-induced oncogenesis. Marek's disease (MD) is also one of the cancers against which a vaccine was first used. In the lymphomas and lymphoblastoid cell lines (LCLs) derived from them, MDV establishes latent infection with limited gene expression. Although LCLs are valuable for interrogating viral and host gene functions, molecular determinants associated with the maintenance of MDV latency and lytic switch remain largely unknown, mainly due to the lack of tools for in situ manipulation of the genomes in these cell lines. Here we describe the first application of CRISPR/Cas9 editing approach for precise editing of the viral gene phosphoprotein 38 (

Indexed as

CRISPR-Cas SystemsGene EditingAnimalsAntigens, ViralCell Line, TransformedDNA End-Joining RepairFlow CytometryGenes, ReporterGene TargetingGenome, ViralHerpesvirus 2, GallidMarek DiseasePhosphoproteinsRNA, Guide, CRISPR-Cas SystemsAntigens, Viralphosphoprotein pp38, Marek's disease virusPhosphoproteinsRNA, Guide, CRISPR-Cas SystemsCRISPR/Cas9GFPMDV-transformed cell linepp38proliferation

Identifiers

PMID31027375
PMCPMC6563304
OpenAlexW2941176611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.